Protara Therapeutics (TARA) Earnings Date & Reports

Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

TARA is expected to report earnings to fall 4.36% to -34 cents per share on October 29

Protara Therapeutics TARA Stock Earnings Reports

Q3'26

Est.

$-0.34

Q2'26

Missed

by $0.02

Q1'26

Beat

by $0.03

Q4'25

Missed

by $0.02

Q3'25

Beat

by $0.07

The last earnings report on August 11 showed earnings per share of -36 cents, missing the estimate of -34 cents. With 138.41K shares outstanding, the current market capitalization sits at 227.52M.

View a ticker or compare two or three

TARA

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days